Clinical Trials : Leishmaniasis

Not yet recruiting

Nombre del estudio: Single Dose Liposomal Amphotericin B for Visceral Leishmaniasis
Condición: Visceral Leishmaniasis
Fecha: 2012-03-27
Intervenciones: Drug: AMBISOME SINGLE DOSE AMBISOME FOR TREATMENT OF VISCERAL LEISHMANIASIS

Terminated

Nombre del estudio: Efficacy and Safety Study of Drugs for Treatment of Visceral Leishmaniasis in Brazil
Condición: Visceral Leishmaniasis
Fecha: 2011-03-07
Intervenciones:

Drug: Antimoniate of N-methylglucamine

Terminated

Nombre del estudio: Safety and Efficacy of Azithromycin to Treat Cutaneous Leishmaniasis
Condición: Cutaneous Leishmaniasis
Fecha: 2008-05-20
Intervenciones:

Drug: Glucantime® 15mg Sb

Completed

Nombre del estudio: Miltefosine to Treat Cutaneous Leishmaniasis in Bolivia
Condición: Cutaneous Leishmaniasis
Fecha: 2005-09-28
Intervenciones:

Drug: miltefosine
Drug: antimony

Completed

Nombre del estudio: Treatment of Leishmaniasis With Impavido® (Miltefosine): Higher-Weight Patient Registry
Condición: Leishmaniasis
Fecha: 2015-04-22
Intervenciones: Drug: Miltefosine miltefosine: target 2.5 mg/kg/day for 28 days

Available

Nombre del estudio: Paromomycin for Individuals With Uncomplicated Cutaneous Leishmaniasis
Condición: Leishmaniasis, Cutaneous
Fecha: 2012-06-18
Intervenciones: Drug: Paromomycin Paromomycin Topical Cream applied to all lesions once a day for 20 days

Completed

Nombre del estudio: Study to Evaluate the Leish-111F + MPL-SE Vaccine in the Treatment of Cutaneous Leishmaniasis
Condición: Leishmaniasis, Cutaneous
Fecha: 2005-05-23
Intervenciones: Biological: Leish-111f + MPL-SE vaccine

Terminated

Nombre del estudio: Safety, Efficacy, and PK of Topical Paromomycin/Gentamicin Cream for Treatment of Cutaneous Leishmaniasis
Condición: Leishmaniasis, Cutaneous
Fecha: 2010-06-07
Intervenciones: Drug: WR 279,396 Topical application of WR 279,396 cream (15% paromomycin + 0.5% gentamicin)once daily f

Completed

Nombre del estudio: Safety, Efficacy and Pharmacokinetics (PK) Study of WR 279,396 Versus Paromomycin for Treatment of Cutaneous Leishmaniasis (Peru-PK)
Condición: Leishmaniasis, Cutaneous
Fecha: 2009-12-14
Intervenciones:

Drug: WR 279,396 (15% paromomycin + 0.5% gentamicin topical cream)

Completed

Nombre del estudio: Pharmacokinetics, Safety, and Efficacy Trial of WR 279,396 (Paromomycin + Gentamicin Topical Cream) and Paromomycin Topical Cream for the Treatment of Cutaneous Leishmaniasis in Panama
Condición: Leishmaniasis, Cutaneous
Fecha: 2010-03-08
Intervenciones:

Drug: WR 279,396 (15% paromomycin + 0.5% gentamicin topical cream)

Buscar resultados de ensayos clínicos

Leishmaniasis - 70 Studies Found

Estado	Estudiar
Not yet recruiting	Nombre del estudio: Single Dose Liposomal Amphotericin B for Visceral Leishmaniasis Condición: Visceral Leishmaniasis Fecha: 2012-03-27 Intervenciones: Drug: AMBISOME SINGLE DOSE AMBISOME FOR TREATMENT OF VISCERAL LEISHMANIASIS
Terminated	Nombre del estudio: Efficacy and Safety Study of Drugs for Treatment of Visceral Leishmaniasis in Brazil Condición: Visceral Leishmaniasis Fecha: 2011-03-07 Intervenciones: Drug: Antimoniate of N-methylglucamine
Terminated	Nombre del estudio: Safety and Efficacy of Azithromycin to Treat Cutaneous Leishmaniasis Condición: Cutaneous Leishmaniasis Fecha: 2008-05-20 Intervenciones: Drug: Glucantime® 15mg Sb
Completed	Nombre del estudio: Miltefosine to Treat Cutaneous Leishmaniasis in Bolivia Condición: Cutaneous Leishmaniasis Fecha: 2005-09-28 Intervenciones: Drug: miltefosine Drug: antimony
Completed	Nombre del estudio: Treatment of Leishmaniasis With Impavido® (Miltefosine): Higher-Weight Patient Registry Condición: Leishmaniasis Fecha: 2015-04-22 Intervenciones: Drug: Miltefosine miltefosine: target 2.5 mg/kg/day for 28 days
Available	Nombre del estudio: Paromomycin for Individuals With Uncomplicated Cutaneous Leishmaniasis Condición: Leishmaniasis, Cutaneous Fecha: 2012-06-18 Intervenciones: Drug: Paromomycin Paromomycin Topical Cream applied to all lesions once a day for 20 days
Completed	Nombre del estudio: Study to Evaluate the Leish-111F + MPL-SE Vaccine in the Treatment of Cutaneous Leishmaniasis Condición: Leishmaniasis, Cutaneous Fecha: 2005-05-23 Intervenciones: Biological: Leish-111f + MPL-SE vaccine
Terminated	Nombre del estudio: Safety, Efficacy, and PK of Topical Paromomycin/Gentamicin Cream for Treatment of Cutaneous Leishmaniasis Condición: Leishmaniasis, Cutaneous Fecha: 2010-06-07 Intervenciones: Drug: WR 279,396 Topical application of WR 279,396 cream (15% paromomycin + 0.5% gentamicin)once daily f
Completed	Nombre del estudio: Safety, Efficacy and Pharmacokinetics (PK) Study of WR 279,396 Versus Paromomycin for Treatment of Cutaneous Leishmaniasis (Peru-PK) Condición: Leishmaniasis, Cutaneous Fecha: 2009-12-14 Intervenciones: Drug: WR 279,396 (15% paromomycin + 0.5% gentamicin topical cream)
Completed	Nombre del estudio: Pharmacokinetics, Safety, and Efficacy Trial of WR 279,396 (Paromomycin + Gentamicin Topical Cream) and Paromomycin Topical Cream for the Treatment of Cutaneous Leishmaniasis in Panama Condición: Leishmaniasis, Cutaneous Fecha: 2010-03-08 Intervenciones: Drug: WR 279,396 (15% paromomycin + 0.5% gentamicin topical cream)